Sun Safety Saturday: Skin Cancer Screening

Translate to Spanish or other 102 languages!

skin cancer screening good

- Advertisement -

Doctors Hospital At Renaissance And Renaissance Cancer Center Provide Free

Skin Cancer Screenings To The Community For Prevention And Early Detection.

Mega Doctor News

- Advertisement -

Edinburg, TX—8/14/2014—According to the Skin Cancer Foundation, skin cancer is the most common form of cancer in the United States, occurring in one in five Americans. Unprotected sun exposure is one of the main risk factors for skin cancer, and summer is the perfect time to remind ourselves about these dangers.

To promote prevention and early detection, Doctors Hospital at Renaissance Cancer Center would like to invite the community to a Sun Safety Saturday: a FREE Skin Cancer Screening event which will take place on Saturday, August 16, 2014 from 9 a.m. to 11:30 a.m. at the Renaissance Cancer Center located at 2717 Michael Angelo Dr. in Edinburg, TX. Dr. Rick Lin, as well as other physicians and PAs will be on site to perform full body skin cancer screenings to the community.

Besides unprotected and excessive sun exposure, other sources of risk factors to skin cancer are UV light from tanning beds and sun lamps. Populations with fair skin color have a higher risk of developing this type of cancer. Skin cancer can start as a single lesion on any skin surface. For signs of occurrence, one should watch for any of the ABCDE symptoms including Asymmetry of moles or growths, Borders which are irregular on moles, Color variations or changes in color of moles, Diameter larger than a pencil eraser, and Enlargement of a mole.

Please join us in our skin cancer screening event and help us promote prevention and early detection. General public of all ages are welcome to attend. To R.S.V.P. please call 956-217-7050.

- Advertisement -

 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.
- Advertisement -